Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 125

1.

A pilot trial of injectable, extended-release naltrexone for the treatment of co-occurring cocaine and alcohol dependence.

Pettinati HM, Kampman KM, Lynch KG, Dundon WD, Mahoney EM, Wierzbicki MR, O'Brien CP.

Am J Addict. 2014 Nov-Dec;23(6):591-7. doi: 10.1111/j.1521-0391.2014.12146.x. Epub 2014 Sep 22.

PMID:
25251201
[PubMed - in process]
2.

The dopamine receptor D2 (DRD2) SNP rs1076560 is associated with opioid addiction.

Clarke TK, Weiss AR, Ferarro TN, Kampman KM, Dackis CA, Pettinati HM, O'brien CP, Oslin DW, Lohoff FW, Berrettini WH.

Ann Hum Genet. 2014 Jan;78(1):33-9. doi: 10.1111/ahg.12046. Epub 2013 Nov 25.

PMID:
24359476
[PubMed - indexed for MEDLINE]
3.

Results from a pilot clinical trial of varenicline for the treatment of alcohol dependence.

Plebani JG, Lynch KG, Rennert L, Pettinati HM, O'Brien CP, Kampman KM.

Drug Alcohol Depend. 2013 Dec 1;133(2):754-8. doi: 10.1016/j.drugalcdep.2013.06.019. Epub 2013 Jul 31.

PMID:
23916324
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

A double-blind, placebo-controlled trial of topiramate for the treatment of comorbid cocaine and alcohol dependence.

Kampman KM, Pettinati HM, Lynch KG, Spratt K, Wierzbicki MR, O'Brien CP.

Drug Alcohol Depend. 2013 Nov 1;133(1):94-9. doi: 10.1016/j.drugalcdep.2013.05.026. Epub 2013 Jun 28.

PMID:
23810644
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

A double-blind, placebo-controlled trial assessing the efficacy of varenicline tartrate for alcohol dependence.

Litten RZ, Ryan ML, Fertig JB, Falk DE, Johnson B, Dunn KE, Green AI, Pettinati HM, Ciraulo DA, Sarid-Segal O, Kampman K, Brunette MF, Strain EC, Tiouririne NA, Ransom J, Scott C, Stout R; NCIG (National Institute on Alcohol Abuse and Alcoholism Clinical Investigations Group) Study Group.

J Addict Med. 2013 Jul-Aug;7(4):277-86. doi: 10.1097/ADM.0b013e31829623f4.

PMID:
23728065
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Case-control association study of WLS variants in opioid and cocaine addicted populations.

Crist RC, Ambrose-Lanci LM, Zeng A, Yuan C, Kampman KM, Pettinati HM, Oslin DW, O'Brien CP, Ferraro TN, Doyle GA, Lohoff FW, Berrettini WH.

Psychiatry Res. 2013 Jun 30;208(1):62-6. doi: 10.1016/j.psychres.2013.03.011. Epub 2013 Apr 5.

PMID:
23566366
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Low frequency genetic variants in the μ-opioid receptor (OPRM1) affect risk for addiction to heroin and cocaine.

Clarke TK, Crist RC, Kampman KM, Dackis CA, Pettinati HM, O'Brien CP, Oslin DW, Ferraro TN, Lohoff FW, Berrettini WH.

Neurosci Lett. 2013 May 10;542:71-5. doi: 10.1016/j.neulet.2013.02.018. Epub 2013 Feb 20.

PMID:
23454283
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Current status of co-occurring mood and substance use disorders: a new therapeutic target.

Pettinati HM, O'Brien CP, Dundon WD.

Am J Psychiatry. 2013 Jan;170(1):23-30. doi: 10.1176/appi.ajp.2012.12010112. Review.

PMID:
23223834
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Neuronal calcium sensor-1 and cocaine addiction: a genetic association study in African-Americans and European Americans.

Multani PK, Clarke TK, Narasimhan S, Ambrose-Lanci L, Kampman KM, Pettinati HM, Oslin DW, O'Brien CP, Berrettini WH, Lohoff FW.

Neurosci Lett. 2012 Nov 30;531(1):46-51. doi: 10.1016/j.neulet.2012.09.014. Epub 2012 Sep 20.

PMID:
22999924
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Case-control association analysis of polymorphisms in the δ-opioid receptor, OPRD1, with cocaine and opioid addicted populations.

Crist RC, Ambrose-Lanci LM, Vaswani M, Clarke TK, Zeng A, Yuan C, Ferraro TN, Hakonarson H, Kampman KM, Dackis CA, Pettinati HM, O'Brien CP, Oslin DW, Doyle GA, Lohoff FW, Berrettini WH.

Drug Alcohol Depend. 2013 Jan 1;127(1-3):122-8. doi: 10.1016/j.drugalcdep.2012.06.023. Epub 2012 Jul 12.

PMID:
22795689
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Genetic association analyses of PDYN polymorphisms with heroin and cocaine addiction.

Clarke TK, Ambrose-Lanci L, Ferraro TN, Berrettini WH, Kampman KM, Dackis CA, Pettinati HM, O'Brien CP, Oslin DW, Lohoff FW.

Genes Brain Behav. 2012 Jun;11(4):415-23. doi: 10.1111/j.1601-183X.2012.00785.x. Epub 2012 Apr 11.

PMID:
22443215
[PubMed - indexed for MEDLINE]
12.

A double-blind, placebo-controlled trial of modafinil for cocaine dependence.

Dackis CA, Kampman KM, Lynch KG, Plebani JG, Pettinati HM, Sparkman T, O'Brien CP.

J Subst Abuse Treat. 2012 Oct;43(3):303-12. doi: 10.1016/j.jsat.2011.12.014. Epub 2012 Feb 27.

PMID:
22377391
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Results of an initial clinical trial of varenicline for the treatment of cocaine dependence.

Plebani JG, Lynch KG, Yu Q, Pettinati HM, O'Brien CP, Kampman KM.

Drug Alcohol Depend. 2012 Feb 1;121(1-2):163-6. doi: 10.1016/j.drugalcdep.2011.08.025. Epub 2011 Sep 16.

PMID:
21925806
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Further evidence for association of polymorphisms in the CNR1 gene with cocaine addiction: confirmation in an independent sample and meta-analysis.

Clarke TK, Bloch PJ, Ambrose-Lanci LM, Ferraro TN, Berrettini WH, Kampman KM, Dackis CA, Pettinati HM, O'Brien CP, Oslin DW, Lohoff FW.

Addict Biol. 2013 Jul;18(4):702-8. doi: 10.1111/j.1369-1600.2011.00346.x. Epub 2011 Jul 25.

PMID:
21790903
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Efficacy of extended-release naltrexone in patients with relatively higher severity of alcohol dependence.

Pettinati HM, Silverman BL, Battisti JJ, Forman R, Schweizer E, Gastfriend DR.

Alcohol Clin Exp Res. 2011 Oct;35(10):1804-11. doi: 10.1111/j.1530-0277.2011.01524.x. Epub 2011 May 16.

PMID:
21575016
[PubMed - indexed for MEDLINE]
16.

Long-term opioid blockade and hedonic response: preliminary data from two open-label extension studies with extended-release naltrexone.

O'Brien CP, Gastfriend DR, Forman RF, Schweizer E, Pettinati HM.

Am J Addict. 2011 Mar-Apr;20(2):106-12. doi: 10.1111/j.1521-0391.2010.00107.x. Epub 2010 Dec 28.

PMID:
21314752
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

A double-blind, placebo-controlled pilot trial of acamprosate for the treatment of cocaine dependence.

Kampman KM, Dackis C, Pettinati HM, Lynch KG, Sparkman T, O'Brien CP.

Addict Behav. 2011 Mar;36(3):217-21. doi: 10.1016/j.addbeh.2010.11.003. Epub 2010 Nov 10.

PMID:
21112155
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Gender differences in alcohol treatment: an analysis of outcome from the COMBINE study.

Greenfield SF, Pettinati HM, O'Malley S, Randall PK, Randall CL.

Alcohol Clin Exp Res. 2010 Oct;34(10):1803-12. doi: 10.1111/j.1530-0277.2010.01267.x. Epub 2010 Jul 20.

PMID:
20645934
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

A double-blind, placebo-controlled study with quetiapine as adjunct therapy with lithium or divalproex in bipolar I patients with coexisting alcohol dependence.

Stedman M, Pettinati HM, Brown ES, Kotz M, Calabrese JR, Raines S.

Alcohol Clin Exp Res. 2010 Oct;34(10):1822-31. doi: 10.1111/j.1530-0277.2010.01270.x. Epub 2010 Jul 19.

PMID:
20626727
[PubMed - indexed for MEDLINE]
20.

A double-blind, placebo-controlled trial combining sertraline and naltrexone for treating co-occurring depression and alcohol dependence.

Pettinati HM, Oslin DW, Kampman KM, Dundon WD, Xie H, Gallis TL, Dackis CA, O'Brien CP.

Am J Psychiatry. 2010 Jun;167(6):668-75. doi: 10.1176/appi.ajp.2009.08060852. Epub 2010 Mar 15.

PMID:
20231324
[PubMed - indexed for MEDLINE]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk